

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 9.00278223 |
| 2 | skeletal muscle contraction (GO:0003009) | 8.91455543 |
| 3 | actin-myosin filament sliding (GO:0033275) | 8.82392777 |
| 4 | muscle filament sliding (GO:0030049) | 8.82392777 |
| 5 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.76526670 |
| 6 | skeletal muscle adaptation (GO:0043501) | 7.68487707 |
| 7 | actin-mediated cell contraction (GO:0070252) | 7.24908094 |
| 8 | skeletal muscle fiber development (GO:0048741) | 6.24711681 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.02649637 |
| 10 | actin filament-based movement (GO:0030048) | 5.62774945 |
| 11 | myotube cell development (GO:0014904) | 5.46129475 |
| 12 | striated muscle contraction (GO:0006941) | 5.43292521 |
| 13 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.34799540 |
| 14 | regulation of cell communication by electrical coupling (GO:0010649) | 5.31690732 |
| 15 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.31268505 |
| 16 | carnitine shuttle (GO:0006853) | 5.30868698 |
| 17 | plasma membrane repair (GO:0001778) | 5.29693535 |
| 18 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.24661060 |
| 19 | creatine metabolic process (GO:0006600) | 5.19706468 |
| 20 | sarcomere organization (GO:0045214) | 5.16125193 |
| 21 | otic vesicle formation (GO:0030916) | 5.11118520 |
| 22 | glycogen catabolic process (GO:0005980) | 5.10952825 |
| 23 | DNA double-strand break processing (GO:0000729) | 5.08141857 |
| 24 | striated muscle atrophy (GO:0014891) | 4.83956315 |
| 25 | glucan catabolic process (GO:0009251) | 4.75882174 |
| 26 | response to inactivity (GO:0014854) | 4.59336095 |
| 27 | cardiac left ventricle morphogenesis (GO:0003214) | 4.55923267 |
| 28 | myofibril assembly (GO:0030239) | 4.45753547 |
| 29 | respiratory chain complex IV assembly (GO:0008535) | 4.44053420 |
| 30 | fatty acid transmembrane transport (GO:1902001) | 4.42855241 |
| 31 | proteasome assembly (GO:0043248) | 4.41394870 |
| 32 | cellular polysaccharide catabolic process (GO:0044247) | 4.36796524 |
| 33 | glycogen biosynthetic process (GO:0005978) | 4.35931399 |
| 34 | glucan biosynthetic process (GO:0009250) | 4.35931399 |
| 35 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.33441996 |
| 36 | muscle contraction (GO:0006936) | 4.32776638 |
| 37 | skeletal muscle tissue regeneration (GO:0043403) | 4.31801353 |
| 38 | response to pheromone (GO:0019236) | 4.23909381 |
| 39 | response to muscle activity (GO:0014850) | 4.18180641 |
| 40 | muscle atrophy (GO:0014889) | 4.16726096 |
| 41 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.10802750 |
| 42 | neuronal action potential propagation (GO:0019227) | 4.10422101 |
| 43 | polysaccharide catabolic process (GO:0000272) | 4.08599112 |
| 44 | synapsis (GO:0007129) | 4.05185812 |
| 45 | dopamine transport (GO:0015872) | 4.01525866 |
| 46 | heterochromatin organization (GO:0070828) | 4.00619130 |
| 47 | neuromuscular synaptic transmission (GO:0007274) | 3.97009575 |
| 48 | striated muscle adaptation (GO:0014888) | 3.95815211 |
| 49 | carnitine transmembrane transport (GO:1902603) | 3.91768549 |
| 50 | regulation of meiosis I (GO:0060631) | 3.90839203 |
| 51 | purine nucleotide salvage (GO:0032261) | 3.88117540 |
| 52 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.87533208 |
| 53 | presynaptic membrane assembly (GO:0097105) | 3.84567105 |
| 54 | muscle system process (GO:0003012) | 3.83663533 |
| 55 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.82297524 |
| 56 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.75835624 |
| 57 | cytochrome complex assembly (GO:0017004) | 3.75140918 |
| 58 | muscle fiber development (GO:0048747) | 3.74181983 |
| 59 | cytidine deamination (GO:0009972) | 3.72479377 |
| 60 | cytidine metabolic process (GO:0046087) | 3.72479377 |
| 61 | cytidine catabolic process (GO:0006216) | 3.72479377 |
| 62 | glycogen metabolic process (GO:0005977) | 3.66124606 |
| 63 | actomyosin structure organization (GO:0031032) | 3.61352115 |
| 64 | glucan metabolic process (GO:0044042) | 3.58064376 |
| 65 | cellular glucan metabolic process (GO:0006073) | 3.58064376 |
| 66 | lactate metabolic process (GO:0006089) | 3.55530183 |
| 67 | DNA methylation involved in gamete generation (GO:0043046) | 3.55406841 |
| 68 | amino-acid betaine transport (GO:0015838) | 3.54912089 |
| 69 | carnitine transport (GO:0015879) | 3.54912089 |
| 70 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.50250622 |
| 71 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.50250622 |
| 72 | NADH dehydrogenase complex assembly (GO:0010257) | 3.50250622 |
| 73 | DNA demethylation (GO:0080111) | 3.46850805 |
| 74 | ovulation cycle (GO:0042698) | 3.43317925 |
| 75 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.38755042 |
| 76 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.38095194 |
| 77 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.38095194 |
| 78 | transcription from mitochondrial promoter (GO:0006390) | 3.29887018 |
| 79 | muscle adaptation (GO:0043500) | 3.29846255 |
| 80 | negative regulation of protein localization to cell surface (GO:2000009) | 3.28331616 |
| 81 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.27598523 |
| 82 | cardiac muscle contraction (GO:0060048) | 3.26499029 |
| 83 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.26419479 |
| 84 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.21131346 |
| 85 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.20150558 |
| 86 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.19167129 |
| 87 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.14518436 |
| 88 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.14406687 |
| 89 | muscle cell cellular homeostasis (GO:0046716) | 3.14400204 |
| 90 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.13895793 |
| 91 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.12060220 |
| 92 | regulation of relaxation of muscle (GO:1901077) | 3.11811646 |
| 93 | muscle structure development (GO:0061061) | 3.11234127 |
| 94 | regulation of membrane repolarization (GO:0060306) | 3.10141895 |
| 95 | muscle organ development (GO:0007517) | 3.09552342 |
| 96 | L-serine metabolic process (GO:0006563) | 3.09169848 |
| 97 | oxidative demethylation (GO:0070989) | 3.09020911 |
| 98 | regulation of actin filament-based movement (GO:1903115) | 3.08979245 |
| 99 | negative regulation of membrane potential (GO:0045837) | 3.08774058 |
| 100 | histone H2A acetylation (GO:0043968) | 3.07520526 |
| 101 | neuromuscular junction development (GO:0007528) | 3.05553009 |
| 102 | aspartate family amino acid catabolic process (GO:0009068) | 3.05191276 |
| 103 | protein complex biogenesis (GO:0070271) | 3.04976767 |
| 104 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.02789643 |
| 105 | branched-chain amino acid catabolic process (GO:0009083) | 3.02420989 |
| 106 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.01051746 |
| 107 | male meiosis I (GO:0007141) | 3.00363727 |
| 108 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.99587256 |
| 109 | presynaptic membrane organization (GO:0097090) | 2.99026589 |
| 110 | lysine metabolic process (GO:0006553) | 2.98440314 |
| 111 | lysine catabolic process (GO:0006554) | 2.98440314 |
| 112 | adult heart development (GO:0007512) | 2.97019932 |
| 113 | C4-dicarboxylate transport (GO:0015740) | 2.95532444 |
| 114 | membrane depolarization during action potential (GO:0086010) | 2.95505191 |
| 115 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.94500591 |
| 116 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.91364898 |
| 117 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.91364898 |
| 118 | forebrain neuron differentiation (GO:0021879) | 2.90276736 |
| 119 | striated muscle cell development (GO:0055002) | 2.88517545 |
| 120 | myotube differentiation (GO:0014902) | 2.86465539 |
| 121 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.85960137 |
| 122 | striatum development (GO:0021756) | 2.85685158 |
| 123 | behavioral response to cocaine (GO:0048148) | 2.85538543 |
| 124 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.84944345 |
| 125 | piRNA metabolic process (GO:0034587) | 2.83618096 |
| 126 | positive regulation of catecholamine secretion (GO:0033605) | 2.82936876 |
| 127 | myoblast fusion (GO:0007520) | 2.82695427 |
| 128 | response to activity (GO:0014823) | 2.80955404 |
| 129 | regulation of striated muscle contraction (GO:0006942) | 2.79415745 |
| 130 | regulation of cardioblast differentiation (GO:0051890) | 2.77832869 |
| 131 | cellular carbohydrate catabolic process (GO:0044275) | 2.76964364 |
| 132 | response to nitrosative stress (GO:0051409) | 2.76757525 |
| 133 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.75831096 |
| 134 | anterior/posterior axis specification, embryo (GO:0008595) | 2.75691110 |
| 135 | negative regulation of sodium ion transport (GO:0010766) | 2.74938836 |
| 136 | regulation of cation channel activity (GO:2001257) | 2.72924442 |
| 137 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.72173237 |
| 138 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.72173237 |
| 139 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.72173237 |
| 140 | positive regulation of catenin import into nucleus (GO:0035413) | 2.70471146 |
| 141 | negative regulation of muscle hypertrophy (GO:0014741) | 2.69621006 |
| 142 | relaxation of cardiac muscle (GO:0055119) | 2.69044636 |
| 143 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.68923423 |
| 144 | signal peptide processing (GO:0006465) | 2.68440674 |
| 145 | regulation of glucokinase activity (GO:0033131) | 2.68296199 |
| 146 | regulation of hexokinase activity (GO:1903299) | 2.68296199 |
| 147 | IMP metabolic process (GO:0046040) | 2.67321464 |
| 148 | axonal fasciculation (GO:0007413) | 2.66324750 |
| 149 | postsynaptic membrane organization (GO:0001941) | 2.66026252 |
| 150 | tongue development (GO:0043586) | 2.65953206 |
| 151 | cardiac myofibril assembly (GO:0055003) | 2.64677580 |
| 152 | negative regulation of potassium ion transport (GO:0043267) | 2.63597055 |
| 153 | positive regulation of cation channel activity (GO:2001259) | 2.62819156 |
| 154 | meiosis I (GO:0007127) | 2.62396659 |
| 155 | regulation of sequestering of calcium ion (GO:0051282) | 2.60993287 |
| 156 | positive regulation of DNA repair (GO:0045739) | 2.60795187 |
| 157 | regulation of cofactor metabolic process (GO:0051193) | 2.60400986 |
| 158 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.59820462 |
| 159 | protein K11-linked deubiquitination (GO:0035871) | 2.56627873 |
| 160 | peptidyl-histidine modification (GO:0018202) | 2.56335048 |
| 161 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.53483178 |
| 162 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.53252159 |
| 163 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.53252159 |
| 164 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.49871647 |
| 165 | behavioral fear response (GO:0001662) | 2.49573256 |
| 166 | behavioral defense response (GO:0002209) | 2.49573256 |
| 167 | replication fork processing (GO:0031297) | 2.49215075 |
| 168 | tachykinin receptor signaling pathway (GO:0007217) | 2.49092649 |
| 169 | pseudouridine synthesis (GO:0001522) | 2.46813778 |
| 170 | purine nucleobase biosynthetic process (GO:0009113) | 2.46591972 |
| 171 | peptidyl-cysteine modification (GO:0018198) | 2.46017645 |
| 172 | cardiac muscle hypertrophy (GO:0003300) | 2.45346767 |
| 173 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.44598331 |
| 174 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.44338287 |
| 175 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.44338287 |
| 176 | cardiac ventricle morphogenesis (GO:0003208) | 2.43494529 |
| 177 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.42157184 |
| 178 | protein heterotetramerization (GO:0051290) | 2.41913749 |
| 179 | double-strand break repair via homologous recombination (GO:0000724) | 2.41080533 |
| 180 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.40744635 |
| 181 | DNA strand renaturation (GO:0000733) | 2.40396336 |
| 182 | recombinational repair (GO:0000725) | 2.39954172 |
| 183 | chromatin remodeling at centromere (GO:0031055) | 2.38117092 |
| 184 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.37313449 |
| 185 | ventricular cardiac muscle cell development (GO:0055015) | 2.36941576 |
| 186 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.34178539 |
| 187 | aldehyde catabolic process (GO:0046185) | 2.33242350 |
| 188 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.32267689 |
| 189 | male meiosis (GO:0007140) | 2.31914789 |
| 190 | negative regulation of neurological system process (GO:0031645) | 2.31282477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.97400599 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.70747523 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.66382511 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.92474230 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.78782403 |
| 6 | * FUS_26573619_Chip-Seq_HEK293_Human | 2.64594016 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.48913234 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.44595204 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.33249296 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.32504692 |
| 11 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.29367955 |
| 12 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.25230587 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.23177849 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.22223709 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21803363 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.18520289 |
| 17 | * P300_19829295_ChIP-Seq_ESCs_Human | 2.17556520 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.12142722 |
| 19 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.11908414 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.11283884 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.11245090 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.09191978 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.07007640 |
| 24 | EWS_26573619_Chip-Seq_HEK293_Human | 2.06408728 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03975950 |
| 26 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.02420953 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.97738200 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.97660383 |
| 29 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.95079946 |
| 30 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.95079946 |
| 31 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.93292852 |
| 32 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.91722554 |
| 33 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.91696683 |
| 34 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.90771332 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.89480944 |
| 36 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.86257313 |
| 37 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.81092928 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.78351041 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.74406413 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73210899 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.71456775 |
| 42 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.70084293 |
| 43 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.66601547 |
| 44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.63956283 |
| 45 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.63436944 |
| 46 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.62646703 |
| 47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.60474011 |
| 48 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.59829571 |
| 49 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.59654544 |
| 50 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.58451122 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56961068 |
| 52 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.53407976 |
| 53 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.52492531 |
| 54 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.51773536 |
| 55 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.50555098 |
| 56 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.49958867 |
| 57 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.47011773 |
| 58 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.46775320 |
| 59 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.45457324 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43828416 |
| 61 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.40792628 |
| 62 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39242237 |
| 63 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37806359 |
| 64 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.37341359 |
| 65 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.36242519 |
| 66 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.35916732 |
| 67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.34703673 |
| 68 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.33394188 |
| 69 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.32928433 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32463147 |
| 71 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.31983017 |
| 72 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.31518617 |
| 73 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.31518617 |
| 74 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.30258514 |
| 75 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.30208283 |
| 76 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.30008296 |
| 77 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.28104548 |
| 78 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28072120 |
| 79 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26373066 |
| 80 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.25886159 |
| 81 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25366865 |
| 82 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24797960 |
| 83 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24720283 |
| 84 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.23723913 |
| 85 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23267696 |
| 86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.22866958 |
| 87 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.22866958 |
| 88 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.22223461 |
| 89 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.21804681 |
| 90 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.21389699 |
| 91 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.20345171 |
| 92 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.20145032 |
| 93 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20032498 |
| 94 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19833035 |
| 95 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19592848 |
| 96 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19215539 |
| 97 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.16569436 |
| 98 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.16065635 |
| 99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15637378 |
| 100 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15514842 |
| 101 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15289621 |
| 102 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.14205662 |
| 103 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.13969991 |
| 104 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13413954 |
| 105 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12677872 |
| 106 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.12165980 |
| 107 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.12031969 |
| 108 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11076263 |
| 109 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09981274 |
| 110 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08785265 |
| 111 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07912018 |
| 112 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07148575 |
| 113 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06384939 |
| 114 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06018694 |
| 115 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.05648769 |
| 116 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.04542682 |
| 117 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04328614 |
| 118 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.04195397 |
| 119 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03994170 |
| 120 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03193770 |
| 121 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.02404799 |
| 122 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02394064 |
| 123 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02339000 |
| 124 | AR_19668381_ChIP-Seq_PC3_Human | 1.01221746 |
| 125 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99976314 |
| 126 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99535056 |
| 127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99336188 |
| 128 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99036570 |
| 129 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98820049 |
| 130 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98609116 |
| 131 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98323793 |
| 132 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98281095 |
| 133 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98281095 |
| 134 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97733985 |
| 135 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97688787 |
| 136 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.97645030 |
| 137 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97575767 |
| 138 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.97348140 |
| 139 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96213649 |
| 140 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95937085 |
| 141 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95883658 |
| 142 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95053834 |
| 143 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.95006117 |
| 144 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93974714 |
| 145 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.93137396 |
| 146 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92979555 |
| 147 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92705758 |
| 148 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.92294999 |
| 149 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92169089 |
| 150 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.91420541 |
| 151 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90619132 |
| 152 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89611594 |
| 153 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89611594 |
| 154 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88298253 |
| 155 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87556792 |
| 156 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87362632 |
| 157 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87221902 |
| 158 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86758125 |
| 159 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.86468849 |
| 160 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.85567279 |
| 161 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.85550743 |
| 162 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.83335664 |
| 163 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.81919756 |
| 164 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81750513 |
| 165 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.80529092 |
| 166 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.80143813 |
| 167 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.79233554 |
| 168 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.79026575 |
| 169 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78849814 |
| 170 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78849814 |
| 171 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.78383884 |
| 172 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.77372789 |
| 173 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.76810706 |
| 174 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.76769534 |
| 175 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.76621475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.86885482 |
| 2 | MP0003646_muscle_fatigue | 5.65378823 |
| 3 | MP0000749_muscle_degeneration | 5.54292060 |
| 4 | MP0000751_myopathy | 5.49147878 |
| 5 | MP0006292_abnormal_olfactory_placode | 4.32348428 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.70107018 |
| 7 | MP0000747_muscle_weakness | 3.69676687 |
| 8 | MP0003880_abnormal_central_pattern | 3.68706943 |
| 9 | MP0002106_abnormal_muscle_physiology | 3.59603671 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 3.44688983 |
| 11 | MP0004130_abnormal_muscle_cell | 3.26093619 |
| 12 | MP0000759_abnormal_skeletal_muscle | 3.26045145 |
| 13 | MP0003136_yellow_coat_color | 3.14772608 |
| 14 | MP0008877_abnormal_DNA_methylation | 3.11756140 |
| 15 | MP0002269_muscular_atrophy | 3.09955776 |
| 16 | MP0004087_abnormal_muscle_fiber | 3.07001252 |
| 17 | MP0005369_muscle_phenotype | 2.92874797 |
| 18 | MP0009379_abnormal_foot_pigmentation | 2.91105953 |
| 19 | MP0005620_abnormal_muscle_contractility | 2.71370308 |
| 20 | MP0004270_analgesia | 2.64856568 |
| 21 | MP0008961_abnormal_basal_metabolism | 2.60060512 |
| 22 | MP0002254_reproductive_system_inflammat | 2.53869865 |
| 23 | MP0000750_abnormal_muscle_regeneration | 2.52191505 |
| 24 | MP0002736_abnormal_nociception_after | 2.47180066 |
| 25 | MP0004233_abnormal_muscle_weight | 2.37462997 |
| 26 | MP0009384_cardiac_valve_regurgitation | 2.37013657 |
| 27 | MP0004859_abnormal_synaptic_plasticity | 2.26824174 |
| 28 | MP0005423_abnormal_somatic_nervous | 2.21270707 |
| 29 | MP0000579_abnormal_nail_morphology | 2.06560296 |
| 30 | MP0000537_abnormal_urethra_morphology | 1.94758639 |
| 31 | MP0002332_abnormal_exercise_endurance | 1.93437942 |
| 32 | MP0000383_abnormal_hair_follicle | 1.89379170 |
| 33 | MP0003122_maternal_imprinting | 1.89318731 |
| 34 | MP0000733_abnormal_muscle_development | 1.87908119 |
| 35 | MP0001986_abnormal_taste_sensitivity | 1.67335732 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.66235106 |
| 37 | MP0002938_white_spotting | 1.64587241 |
| 38 | MP0005330_cardiomyopathy | 1.63300416 |
| 39 | MP0004215_abnormal_myocardial_fiber | 1.60736431 |
| 40 | MP0001293_anophthalmia | 1.59095705 |
| 41 | MP0003119_abnormal_digestive_system | 1.58953572 |
| 42 | MP0006138_congestive_heart_failure | 1.58112397 |
| 43 | MP0004084_abnormal_cardiac_muscle | 1.57522809 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.54884321 |
| 45 | MP0002163_abnormal_gland_morphology | 1.51777754 |
| 46 | MP0008058_abnormal_DNA_repair | 1.50957190 |
| 47 | MP0000427_abnormal_hair_cycle | 1.48280224 |
| 48 | MP0010094_abnormal_chromosome_stability | 1.48216976 |
| 49 | MP0000566_synostosis | 1.47380479 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.45948440 |
| 51 | MP0010307_abnormal_tumor_latency | 1.40660866 |
| 52 | MP0004957_abnormal_blastocyst_morpholog | 1.39599024 |
| 53 | MP0008789_abnormal_olfactory_epithelium | 1.39395968 |
| 54 | MP0005253_abnormal_eye_physiology | 1.38963146 |
| 55 | MP0006072_abnormal_retinal_apoptosis | 1.36525887 |
| 56 | MP0002108_abnormal_muscle_morphology | 1.36495578 |
| 57 | MP0000516_abnormal_urinary_system | 1.34201148 |
| 58 | MP0005367_renal/urinary_system_phenotyp | 1.34201148 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 1.33959915 |
| 60 | MP0001849_ear_inflammation | 1.33789799 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.33504656 |
| 62 | MP0003693_abnormal_embryo_hatching | 1.32372417 |
| 63 | MP0001440_abnormal_grooming_behavior | 1.28484972 |
| 64 | MP0002972_abnormal_cardiac_muscle | 1.26589942 |
| 65 | MP0003718_maternal_effect | 1.26113039 |
| 66 | MP0002233_abnormal_nose_morphology | 1.24921809 |
| 67 | MP0002971_abnormal_brown_adipose | 1.22888362 |
| 68 | MP0004484_altered_response_of | 1.21789262 |
| 69 | MP0000538_abnormal_urinary_bladder | 1.21440386 |
| 70 | MP0001968_abnormal_touch/_nociception | 1.21227821 |
| 71 | MP0010678_abnormal_skin_adnexa | 1.21074276 |
| 72 | MP0001764_abnormal_homeostasis | 1.17946845 |
| 73 | MP0004142_abnormal_muscle_tone | 1.14063426 |
| 74 | MP0002160_abnormal_reproductive_system | 1.12664536 |
| 75 | MP0006054_spinal_hemorrhage | 1.12298176 |
| 76 | MP0008057_abnormal_DNA_replication | 1.12141801 |
| 77 | MP0005266_abnormal_metabolism | 1.11895198 |
| 78 | MP0001346_abnormal_lacrimal_gland | 1.09696729 |
| 79 | MP0005666_abnormal_adipose_tissue | 1.07727886 |
| 80 | MP0002063_abnormal_learning/memory/cond | 1.07547047 |
| 81 | MP0005645_abnormal_hypothalamus_physiol | 1.07491817 |
| 82 | MP0008995_early_reproductive_senescence | 1.06109816 |
| 83 | MP0000778_abnormal_nervous_system | 1.05005382 |
| 84 | MP0003937_abnormal_limbs/digits/tail_de | 1.04787894 |
| 85 | MP0003635_abnormal_synaptic_transmissio | 1.03636368 |
| 86 | MP0001177_atelectasis | 1.03602017 |
| 87 | MP0006276_abnormal_autonomic_nervous | 0.99619968 |
| 88 | MP0010630_abnormal_cardiac_muscle | 0.98426887 |
| 89 | MP0003137_abnormal_impulse_conducting | 0.95937937 |
| 90 | MP0000647_abnormal_sebaceous_gland | 0.95123785 |
| 91 | MP0009745_abnormal_behavioral_response | 0.94478202 |
| 92 | MP0005375_adipose_tissue_phenotype | 0.93068227 |
| 93 | MP0005646_abnormal_pituitary_gland | 0.91614772 |
| 94 | MP0006035_abnormal_mitochondrial_morpho | 0.90455211 |
| 95 | MP0004147_increased_porphyrin_level | 0.90199180 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.89920918 |
| 97 | MP0008569_lethality_at_weaning | 0.89883840 |
| 98 | MP0004264_abnormal_extraembryonic_tissu | 0.88538183 |
| 99 | MP0001286_abnormal_eye_development | 0.88494049 |
| 100 | MP0004134_abnormal_chest_morphology | 0.88194577 |
| 101 | MP0002210_abnormal_sex_determination | 0.87923451 |
| 102 | MP0002697_abnormal_eye_size | 0.86045993 |
| 103 | MP0005391_vision/eye_phenotype | 0.85463893 |
| 104 | MP0000631_abnormal_neuroendocrine_gland | 0.84390780 |
| 105 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83852854 |
| 106 | MP0003890_abnormal_embryonic-extraembry | 0.83005482 |
| 107 | MP0008872_abnormal_physiological_respon | 0.82531582 |
| 108 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81645353 |
| 109 | MP0003938_abnormal_ear_development | 0.81015948 |
| 110 | MP0001529_abnormal_vocalization | 0.80458176 |
| 111 | MP0002822_catalepsy | 0.80426911 |
| 112 | MP0002064_seizures | 0.79155124 |
| 113 | MP0009053_abnormal_anal_canal | 0.78259159 |
| 114 | MP0001929_abnormal_gametogenesis | 0.78072898 |
| 115 | MP0001502_abnormal_circadian_rhythm | 0.77695458 |
| 116 | MP0005394_taste/olfaction_phenotype | 0.77191695 |
| 117 | MP0005499_abnormal_olfactory_system | 0.77191695 |
| 118 | MP0001544_abnormal_cardiovascular_syste | 0.76327341 |
| 119 | MP0005385_cardiovascular_system_phenoty | 0.76327341 |
| 120 | MP0003786_premature_aging | 0.76248513 |
| 121 | MP0005395_other_phenotype | 0.76083547 |
| 122 | MP0003186_abnormal_redox_activity | 0.76052789 |
| 123 | MP0008007_abnormal_cellular_replicative | 0.74794927 |
| 124 | MP0003077_abnormal_cell_cycle | 0.74766087 |
| 125 | MP0000003_abnormal_adipose_tissue | 0.74677138 |
| 126 | MP0009672_abnormal_birth_weight | 0.73877031 |
| 127 | MP0001984_abnormal_olfaction | 0.72906280 |
| 128 | MP0003879_abnormal_hair_cell | 0.70697796 |
| 129 | MP0004133_heterotaxia | 0.70597052 |
| 130 | MP0002734_abnormal_mechanical_nocicepti | 0.70240108 |
| 131 | MP0002095_abnormal_skin_pigmentation | 0.69320244 |
| 132 | MP0002272_abnormal_nervous_system | 0.68518664 |
| 133 | MP0003656_abnormal_erythrocyte_physiolo | 0.66806148 |
| 134 | MP0002127_abnormal_cardiovascular_syste | 0.65811956 |
| 135 | MP0010030_abnormal_orbit_morphology | 0.64879216 |
| 136 | MP0003329_amyloid_beta_deposits | 0.63371508 |
| 137 | MP0002638_abnormal_pupillary_reflex | 0.63294845 |
| 138 | MP0002066_abnormal_motor_capabilities/c | 0.62917110 |
| 139 | MP0005535_abnormal_body_temperature | 0.62614733 |
| 140 | MP0003950_abnormal_plasma_membrane | 0.61573138 |
| 141 | MP0002557_abnormal_social/conspecific_i | 0.61148816 |
| 142 | MP0005334_abnormal_fat_pad | 0.60530552 |
| 143 | MP0005248_abnormal_Harderian_gland | 0.60474292 |
| 144 | MP0002078_abnormal_glucose_homeostasis | 0.59891471 |
| 145 | MP0001299_abnormal_eye_distance/ | 0.58900917 |
| 146 | MP0004085_abnormal_heartbeat | 0.58889142 |
| 147 | MP0002234_abnormal_pharynx_morphology | 0.58400798 |
| 148 | MP0005670_abnormal_white_adipose | 0.58295431 |
| 149 | MP0004858_abnormal_nervous_system | 0.58234289 |
| 150 | MP0002067_abnormal_sensory_capabilities | 0.56834687 |
| 151 | MP0008775_abnormal_heart_ventricle | 0.56679365 |
| 152 | MP0002733_abnormal_thermal_nociception | 0.56637593 |
| 153 | MP0003828_pulmonary_edema | 0.56486324 |
| 154 | MP0004811_abnormal_neuron_physiology | 0.55029531 |
| 155 | MP0001486_abnormal_startle_reflex | 0.51917617 |
| 156 | MP0002572_abnormal_emotion/affect_behav | 0.51842208 |
| 157 | MP0000920_abnormal_myelination | 0.51182359 |
| 158 | MP0002909_abnormal_adrenal_gland | 0.50889780 |
| 159 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.50791252 |
| 160 | MP0003121_genomic_imprinting | 0.50499953 |
| 161 | MP0009250_abnormal_appendicular_skeleto | 0.50192707 |
| 162 | MP0003948_abnormal_gas_homeostasis | 0.50144024 |
| 163 | MP0005452_abnormal_adipose_tissue | 0.48695840 |
| 164 | MP0004043_abnormal_pH_regulation | 0.47843564 |
| 165 | MP0005187_abnormal_penis_morphology | 0.47774669 |
| 166 | MP0003075_altered_response_to | 0.46680321 |
| 167 | MP0002882_abnormal_neuron_morphology | 0.46021033 |
| 168 | MP0001485_abnormal_pinna_reflex | 0.45626574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.85122119 |
| 2 | Exercise-induced myalgia (HP:0003738) | 8.60252822 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.44255738 |
| 4 | Nemaline bodies (HP:0003798) | 7.85354767 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 7.73759626 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.88016441 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 6.26993830 |
| 8 | Distal arthrogryposis (HP:0005684) | 6.06218279 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 6.06140260 |
| 10 | Myopathic facies (HP:0002058) | 5.84188788 |
| 11 | Round ear (HP:0100830) | 5.49331968 |
| 12 | Myoglobinuria (HP:0002913) | 5.30536212 |
| 13 | Difficulty running (HP:0009046) | 5.18377780 |
| 14 | Ulnar deviation of the wrist (HP:0003049) | 4.83484892 |
| 15 | Muscle stiffness (HP:0003552) | 4.67402047 |
| 16 | Muscle fiber splitting (HP:0003555) | 4.63020337 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 4.49520127 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 4.33081513 |
| 19 | Rhabdomyolysis (HP:0003201) | 4.31066352 |
| 20 | Calcaneovalgus deformity (HP:0001848) | 4.29071557 |
| 21 | Myotonia (HP:0002486) | 4.06120540 |
| 22 | Absent phalangeal crease (HP:0006109) | 4.03530845 |
| 23 | Abnormality of the calf musculature (HP:0001430) | 4.02929206 |
| 24 | Deformed tarsal bones (HP:0008119) | 3.87112850 |
| 25 | Increased connective tissue (HP:0009025) | 3.85550140 |
| 26 | 3-Methylglutaconic aciduria (HP:0003535) | 3.73303826 |
| 27 | Abnormal finger flexion creases (HP:0006143) | 3.52326234 |
| 28 | Acute necrotizing encephalopathy (HP:0006965) | 3.49513857 |
| 29 | Malignant hyperthermia (HP:0002047) | 3.49135711 |
| 30 | Abnormality of the labia minora (HP:0012880) | 3.46504003 |
| 31 | Sudden death (HP:0001699) | 3.33800723 |
| 32 | Difficulty climbing stairs (HP:0003551) | 3.31285128 |
| 33 | Subaortic stenosis (HP:0001682) | 3.27827058 |
| 34 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.27827058 |
| 35 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.23725141 |
| 36 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.22450417 |
| 37 | Abnormality of alanine metabolism (HP:0010916) | 3.22450417 |
| 38 | Hyperalaninemia (HP:0003348) | 3.22450417 |
| 39 | Shoulder girdle muscle weakness (HP:0003547) | 3.20676115 |
| 40 | Atonic seizures (HP:0010819) | 3.18781670 |
| 41 | Progressive macrocephaly (HP:0004481) | 3.16683116 |
| 42 | Pelvic girdle muscle weakness (HP:0003749) | 3.15928931 |
| 43 | Acute encephalopathy (HP:0006846) | 3.15116091 |
| 44 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.08255656 |
| 45 | Rimmed vacuoles (HP:0003805) | 3.05762541 |
| 46 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.03418772 |
| 47 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.03418772 |
| 48 | Neck muscle weakness (HP:0000467) | 3.03084553 |
| 49 | Increased variability in muscle fiber diameter (HP:0003557) | 2.98072903 |
| 50 | Focal motor seizures (HP:0011153) | 2.93736133 |
| 51 | Hyperglycinuria (HP:0003108) | 2.93693091 |
| 52 | Oligomenorrhea (HP:0000876) | 2.93187690 |
| 53 | Asymmetric septal hypertrophy (HP:0001670) | 2.90571404 |
| 54 | Pendular nystagmus (HP:0012043) | 2.87280777 |
| 55 | Hyperkalemia (HP:0002153) | 2.86650739 |
| 56 | Volvulus (HP:0002580) | 2.86572898 |
| 57 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.80555402 |
| 58 | Abnormality of glycine metabolism (HP:0010895) | 2.80555402 |
| 59 | Increased CSF lactate (HP:0002490) | 2.79678354 |
| 60 | Glioma (HP:0009733) | 2.79216979 |
| 61 | Frequent falls (HP:0002359) | 2.70967156 |
| 62 | Bifid tongue (HP:0010297) | 2.64624714 |
| 63 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.64007191 |
| 64 | Areflexia of lower limbs (HP:0002522) | 2.62252396 |
| 65 | Abnormality of macular pigmentation (HP:0008002) | 2.61408641 |
| 66 | Abnormality of serum amino acid levels (HP:0003112) | 2.59793207 |
| 67 | Abnormality of the astrocytes (HP:0100707) | 2.57450490 |
| 68 | Astrocytoma (HP:0009592) | 2.57450490 |
| 69 | Pancreatic fibrosis (HP:0100732) | 2.56732248 |
| 70 | Ectopic kidney (HP:0000086) | 2.56201321 |
| 71 | Intestinal atresia (HP:0011100) | 2.50242013 |
| 72 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.49304338 |
| 73 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.48937471 |
| 74 | Pancreatic cysts (HP:0001737) | 2.48791518 |
| 75 | Ependymoma (HP:0002888) | 2.48583924 |
| 76 | Birth length less than 3rd percentile (HP:0003561) | 2.45759680 |
| 77 | Abnormality of the calcaneus (HP:0008364) | 2.44729735 |
| 78 | Polyphagia (HP:0002591) | 2.41984966 |
| 79 | EMG: neuropathic changes (HP:0003445) | 2.39553803 |
| 80 | Abnormality of the neuromuscular junction (HP:0003398) | 2.38619691 |
| 81 | Fatigable weakness (HP:0003473) | 2.38619691 |
| 82 | Failure to thrive in infancy (HP:0001531) | 2.37014671 |
| 83 | Ventricular tachycardia (HP:0004756) | 2.36389040 |
| 84 | Hyperglycinemia (HP:0002154) | 2.35940153 |
| 85 | Hyperventilation (HP:0002883) | 2.34190494 |
| 86 | Cerebral edema (HP:0002181) | 2.32337352 |
| 87 | Septo-optic dysplasia (HP:0100842) | 2.31635588 |
| 88 | True hermaphroditism (HP:0010459) | 2.31538925 |
| 89 | Molar tooth sign on MRI (HP:0002419) | 2.31286969 |
| 90 | Abnormality of midbrain morphology (HP:0002418) | 2.31286969 |
| 91 | Mitochondrial inheritance (HP:0001427) | 2.30646814 |
| 92 | Hepatocellular necrosis (HP:0001404) | 2.29927191 |
| 93 | Severe visual impairment (HP:0001141) | 2.28909752 |
| 94 | Shawl scrotum (HP:0000049) | 2.28301157 |
| 95 | Type I transferrin isoform profile (HP:0003642) | 2.26443844 |
| 96 | Muscular dystrophy (HP:0003560) | 2.24995550 |
| 97 | Limb-girdle muscle weakness (HP:0003325) | 2.24248847 |
| 98 | Horizontal nystagmus (HP:0000666) | 2.24247577 |
| 99 | Hepatic necrosis (HP:0002605) | 2.22961331 |
| 100 | Hypoplastic ischia (HP:0003175) | 2.22624246 |
| 101 | Nephronophthisis (HP:0000090) | 2.20426110 |
| 102 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.19883388 |
| 103 | Distal lower limb muscle weakness (HP:0009053) | 2.18928906 |
| 104 | Abnormality of chromosome stability (HP:0003220) | 2.17693852 |
| 105 | Occipital encephalocele (HP:0002085) | 2.15341108 |
| 106 | Paralysis (HP:0003470) | 2.15209256 |
| 107 | Colon cancer (HP:0003003) | 2.15003346 |
| 108 | Hemiparesis (HP:0001269) | 2.11269093 |
| 109 | Proximal amyotrophy (HP:0007126) | 2.10969599 |
| 110 | Chromsome breakage (HP:0040012) | 2.08705297 |
| 111 | Slender build (HP:0001533) | 2.08466752 |
| 112 | Absent radius (HP:0003974) | 2.08177477 |
| 113 | Bile duct proliferation (HP:0001408) | 2.08000561 |
| 114 | Abnormal biliary tract physiology (HP:0012439) | 2.08000561 |
| 115 | Atrial fibrillation (HP:0005110) | 2.07133330 |
| 116 | Nonprogressive disorder (HP:0003680) | 2.06361820 |
| 117 | Gowers sign (HP:0003391) | 2.04294832 |
| 118 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.03465801 |
| 119 | Microglossia (HP:0000171) | 2.03040820 |
| 120 | Gastrointestinal atresia (HP:0002589) | 2.02271002 |
| 121 | Stomach cancer (HP:0012126) | 2.01655952 |
| 122 | Meckel diverticulum (HP:0002245) | 2.00292252 |
| 123 | Limb-girdle muscle atrophy (HP:0003797) | 1.99967733 |
| 124 | Increased serum lactate (HP:0002151) | 1.98969632 |
| 125 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.98594930 |
| 126 | Stenosis of the external auditory canal (HP:0000402) | 1.96299797 |
| 127 | Preaxial foot polydactyly (HP:0001841) | 1.95707209 |
| 128 | Tetraplegia (HP:0002445) | 1.95685684 |
| 129 | Aplasia involving forearm bones (HP:0009822) | 1.93047125 |
| 130 | Absent forearm bone (HP:0003953) | 1.93047125 |
| 131 | Stridor (HP:0010307) | 1.92762329 |
| 132 | Renal hypoplasia (HP:0000089) | 1.92100903 |
| 133 | Abnormality of the ischium (HP:0003174) | 1.91135721 |
| 134 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.90400637 |
| 135 | Abnormality of the preputium (HP:0100587) | 1.90143814 |
| 136 | X-linked dominant inheritance (HP:0001423) | 1.90084622 |
| 137 | Dialeptic seizures (HP:0011146) | 1.89196512 |
| 138 | Generalized muscle weakness (HP:0003324) | 1.88930464 |
| 139 | Sclerocornea (HP:0000647) | 1.88296004 |
| 140 | Abnormality of the ileum (HP:0001549) | 1.85679761 |
| 141 | Scapular winging (HP:0003691) | 1.85414149 |
| 142 | Fetal akinesia sequence (HP:0001989) | 1.85092365 |
| 143 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.85063957 |
| 144 | Optic disc pallor (HP:0000543) | 1.84956691 |
| 145 | Ulnar deviation of finger (HP:0009465) | 1.84614332 |
| 146 | Erythroderma (HP:0001019) | 1.83853213 |
| 147 | Cerebellar dysplasia (HP:0007033) | 1.83185619 |
| 148 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.82452177 |
| 149 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.81555784 |
| 150 | Lactic acidosis (HP:0003128) | 1.80915309 |
| 151 | Preaxial hand polydactyly (HP:0001177) | 1.76307471 |
| 152 | Weak cry (HP:0001612) | 1.76210250 |
| 153 | Supraventricular tachycardia (HP:0004755) | 1.75377269 |
| 154 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.74925714 |
| 155 | Primary atrial arrhythmia (HP:0001692) | 1.74508135 |
| 156 | Bundle branch block (HP:0011710) | 1.74443241 |
| 157 | Right ventricular cardiomyopathy (HP:0011663) | 1.72687779 |
| 158 | Supraventricular arrhythmia (HP:0005115) | 1.72572927 |
| 159 | Small hand (HP:0200055) | 1.72265302 |
| 160 | Abnormality of the renal medulla (HP:0100957) | 1.71864601 |
| 161 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.71816343 |
| 162 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.71816343 |
| 163 | Abnormal protein glycosylation (HP:0012346) | 1.71816343 |
| 164 | Abnormal glycosylation (HP:0012345) | 1.71816343 |
| 165 | Amelogenesis imperfecta (HP:0000705) | 1.70200468 |
| 166 | Postaxial foot polydactyly (HP:0001830) | 1.69834491 |
| 167 | Generalized tonic-clonic seizures (HP:0002069) | 1.69367989 |
| 168 | Bulbar palsy (HP:0001283) | 1.67987132 |
| 169 | Waddling gait (HP:0002515) | 1.65216532 |
| 170 | Abnormal eating behavior (HP:0100738) | 1.64601170 |
| 171 | Increased purine levels (HP:0004368) | 1.64070780 |
| 172 | Hyperuricemia (HP:0002149) | 1.64070780 |
| 173 | Distal lower limb amyotrophy (HP:0008944) | 1.62960106 |
| 174 | Ankle clonus (HP:0011448) | 1.62195377 |
| 175 | Achilles tendon contracture (HP:0001771) | 1.62186381 |
| 176 | Urinary urgency (HP:0000012) | 1.61365983 |
| 177 | Increased serum pyruvate (HP:0003542) | 1.59115451 |
| 178 | Abnormality of glycolysis (HP:0004366) | 1.59115451 |
| 179 | Metatarsus adductus (HP:0001840) | 1.59050393 |
| 180 | Focal seizures (HP:0007359) | 1.51893954 |
| 181 | Tarsal synostosis (HP:0008368) | 1.50150295 |
| 182 | Dilated cardiomyopathy (HP:0001644) | 1.49955595 |
| 183 | Spinal rigidity (HP:0003306) | 1.49203667 |
| 184 | Gout (HP:0001997) | 1.48453533 |
| 185 | Abnormality of the Achilles tendon (HP:0005109) | 1.48403279 |
| 186 | Progressive muscle weakness (HP:0003323) | 1.48050938 |
| 187 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.47724846 |
| 188 | Facial diplegia (HP:0001349) | 1.47693607 |
| 189 | Increased density of long bones (HP:0006392) | 1.47678417 |
| 190 | Abnormality of the pubic bones (HP:0003172) | 1.47528263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 5.86901104 |
| 2 | OBSCN | 5.71665048 |
| 3 | PHKG1 | 4.90637692 |
| 4 | PHKG2 | 4.90637692 |
| 5 | TTN | 4.44847929 |
| 6 | FRK | 3.66824915 |
| 7 | ZAK | 3.50142723 |
| 8 | PBK | 3.49060713 |
| 9 | ERBB4 | 3.22430428 |
| 10 | FGFR2 | 3.14575512 |
| 11 | WNK3 | 2.96040852 |
| 12 | CASK | 2.78304033 |
| 13 | PNCK | 2.74751306 |
| 14 | NME1 | 2.64444688 |
| 15 | TTK | 2.58822953 |
| 16 | STK16 | 2.49515697 |
| 17 | MAP2K4 | 2.43910622 |
| 18 | LATS1 | 2.43258329 |
| 19 | FGFR4 | 2.36495187 |
| 20 | TRIB3 | 2.21106709 |
| 21 | TRIM28 | 2.17368626 |
| 22 | NTRK2 | 2.13046521 |
| 23 | TYRO3 | 2.12760823 |
| 24 | MAP3K12 | 2.07898946 |
| 25 | PINK1 | 2.04861138 |
| 26 | STK38L | 1.87879163 |
| 27 | PIK3CG | 1.85003499 |
| 28 | DMPK | 1.78719818 |
| 29 | PLK2 | 1.65648861 |
| 30 | UHMK1 | 1.62473042 |
| 31 | BUB1 | 1.60557363 |
| 32 | NUAK1 | 1.58540000 |
| 33 | MAP3K7 | 1.58340136 |
| 34 | PLK3 | 1.52923979 |
| 35 | NEK1 | 1.52104380 |
| 36 | EIF2AK3 | 1.51936414 |
| 37 | TNIK | 1.50889266 |
| 38 | PAK6 | 1.44447978 |
| 39 | VRK2 | 1.43664158 |
| 40 | PDGFRA | 1.32591765 |
| 41 | SRPK1 | 1.27500129 |
| 42 | MET | 1.26760740 |
| 43 | MARK1 | 1.26735411 |
| 44 | MUSK | 1.26042539 |
| 45 | MAP2K3 | 1.21219978 |
| 46 | FGFR3 | 1.14947617 |
| 47 | NLK | 1.14786660 |
| 48 | MAP3K4 | 1.11304475 |
| 49 | PIK3CA | 1.09334257 |
| 50 | MAPK12 | 1.07503891 |
| 51 | MAP2K6 | 1.02750174 |
| 52 | CDK3 | 0.99559052 |
| 53 | MAP3K6 | 0.97562299 |
| 54 | IRAK2 | 0.95324188 |
| 55 | MKNK2 | 0.92076623 |
| 56 | PDK4 | 0.91338716 |
| 57 | PDK3 | 0.91338716 |
| 58 | MAP3K11 | 0.90325585 |
| 59 | PLK1 | 0.87961937 |
| 60 | CDK19 | 0.87707507 |
| 61 | TSSK6 | 0.87027143 |
| 62 | PRPF4B | 0.86533828 |
| 63 | OXSR1 | 0.85269627 |
| 64 | PRKCE | 0.82657542 |
| 65 | SIK3 | 0.81501404 |
| 66 | CAMK1G | 0.80455472 |
| 67 | NEK2 | 0.79885661 |
| 68 | ATR | 0.78779926 |
| 69 | MST4 | 0.73870845 |
| 70 | IRAK1 | 0.73449066 |
| 71 | CSNK1G1 | 0.70950262 |
| 72 | BCR | 0.70518161 |
| 73 | ERBB3 | 0.69958143 |
| 74 | RET | 0.69894872 |
| 75 | ERBB2 | 0.69548962 |
| 76 | MAPK13 | 0.69130093 |
| 77 | TAOK2 | 0.69114052 |
| 78 | NTRK3 | 0.67873895 |
| 79 | BRSK2 | 0.67592337 |
| 80 | RIPK1 | 0.67209971 |
| 81 | KSR1 | 0.66500293 |
| 82 | PLK4 | 0.64968102 |
| 83 | CLK1 | 0.63731810 |
| 84 | BCKDK | 0.63338660 |
| 85 | TESK1 | 0.62570141 |
| 86 | GRK1 | 0.62259538 |
| 87 | BMPR1B | 0.62116507 |
| 88 | ITK | 0.61887975 |
| 89 | ATM | 0.61321166 |
| 90 | MINK1 | 0.60208851 |
| 91 | CHEK2 | 0.59060776 |
| 92 | PASK | 0.57576603 |
| 93 | MARK3 | 0.56855303 |
| 94 | VRK1 | 0.56836410 |
| 95 | PRKAA2 | 0.56054330 |
| 96 | FGFR1 | 0.55511787 |
| 97 | PRKAA1 | 0.54836732 |
| 98 | MAPKAPK3 | 0.54732084 |
| 99 | MAPKAPK5 | 0.54141385 |
| 100 | DDR2 | 0.53789982 |
| 101 | MAP2K7 | 0.53781499 |
| 102 | FER | 0.53584251 |
| 103 | EPHB2 | 0.52607861 |
| 104 | CDC7 | 0.52110979 |
| 105 | MAP3K5 | 0.51685816 |
| 106 | STK4 | 0.51091837 |
| 107 | MAP2K2 | 0.49194749 |
| 108 | CAMK2D | 0.48334512 |
| 109 | ADRBK1 | 0.47710748 |
| 110 | MKNK1 | 0.47067504 |
| 111 | ADRBK2 | 0.46911478 |
| 112 | AKT2 | 0.43866098 |
| 113 | PDK2 | 0.43793713 |
| 114 | EIF2AK2 | 0.41978413 |
| 115 | SIK2 | 0.41809944 |
| 116 | INSRR | 0.41028048 |
| 117 | CDK5 | 0.40758152 |
| 118 | ICK | 0.39923086 |
| 119 | STK39 | 0.39565769 |
| 120 | CAMK2G | 0.39133417 |
| 121 | EPHA4 | 0.38232077 |
| 122 | CSNK1G3 | 0.38035275 |
| 123 | CSNK1A1L | 0.38005326 |
| 124 | ALK | 0.37861637 |
| 125 | MAPK4 | 0.37372643 |
| 126 | SGK1 | 0.37027936 |
| 127 | PRKD1 | 0.36499956 |
| 128 | WEE1 | 0.36341721 |
| 129 | MAP4K2 | 0.36051452 |
| 130 | STK3 | 0.35839089 |
| 131 | LIMK1 | 0.35620751 |
| 132 | TAF1 | 0.34856333 |
| 133 | ROCK1 | 0.34274932 |
| 134 | CHEK1 | 0.33381386 |
| 135 | PAK3 | 0.33310833 |
| 136 | EPHB1 | 0.33296719 |
| 137 | PRKCI | 0.32801507 |
| 138 | DYRK2 | 0.31729720 |
| 139 | CDK18 | 0.30947668 |
| 140 | LATS2 | 0.30697633 |
| 141 | TGFBR1 | 0.30263659 |
| 142 | EGFR | 0.30043803 |
| 143 | PKN1 | 0.29821524 |
| 144 | PRKACB | 0.29747034 |
| 145 | CSNK1D | 0.29637085 |
| 146 | TGFBR2 | 0.29450064 |
| 147 | MYLK | 0.29376746 |
| 148 | PRKDC | 0.29298727 |
| 149 | ILK | 0.28662016 |
| 150 | MAP3K1 | 0.28197947 |
| 151 | TRPM7 | 0.26976766 |
| 152 | CDK15 | 0.26363912 |
| 153 | CDK11A | 0.26264258 |
| 154 | CDK14 | 0.25936814 |
| 155 | PDPK1 | 0.24817608 |
| 156 | RPS6KA3 | 0.24336771 |
| 157 | SIK1 | 0.24107571 |
| 158 | CAMK2B | 0.22556989 |
| 159 | MARK2 | 0.21967374 |
| 160 | BMX | 0.21684094 |
| 161 | CAMK2A | 0.21247621 |
| 162 | LRRK2 | 0.20805970 |
| 163 | PDGFRB | 0.20687669 |
| 164 | PDK1 | 0.20624025 |
| 165 | PRKACG | 0.20463716 |
| 166 | CAMKK2 | 0.18795620 |
| 167 | MAPK11 | 0.17318835 |
| 168 | HCK | 0.17297589 |
| 169 | PRKCG | 0.16248466 |
| 170 | PRKD3 | 0.15084515 |
| 171 | PRKACA | 0.14760834 |
| 172 | CAMK1 | 0.14269172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.24757844 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.09689806 |
| 3 | Circadian rhythm_Homo sapiens_hsa04710 | 3.08720244 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.04140684 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.95236837 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.74438937 |
| 7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.73225348 |
| 8 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.63357695 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.54606773 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.51459705 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.46666063 |
| 12 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.17067501 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.12391885 |
| 14 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.11818442 |
| 15 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.91211768 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.85652443 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81740230 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.80253988 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.79217060 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 1.74927435 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.73136706 |
| 22 | Basal transcription factors_Homo sapiens_hsa03022 | 1.72589396 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.71920067 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.69681822 |
| 25 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.69460593 |
| 26 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.68610412 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.64086134 |
| 28 | RNA degradation_Homo sapiens_hsa03018 | 1.61677871 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.61188508 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.60018952 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.57504057 |
| 32 | Mismatch repair_Homo sapiens_hsa03430 | 1.56191013 |
| 33 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.51855915 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.41353734 |
| 35 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.40751341 |
| 36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.37492049 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.37099139 |
| 38 | Insulin secretion_Homo sapiens_hsa04911 | 1.35333395 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.29717448 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26863372 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.25028158 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.24772073 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.24735928 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24455960 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23578133 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.21836533 |
| 47 | Circadian entrainment_Homo sapiens_hsa04713 | 1.20137244 |
| 48 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.18419316 |
| 49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.18395419 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17814468 |
| 51 | Lysine degradation_Homo sapiens_hsa00310 | 1.16938672 |
| 52 | GABAergic synapse_Homo sapiens_hsa04727 | 1.16710037 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.16368589 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 1.14546437 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12820337 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12066520 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11451644 |
| 58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.11161477 |
| 59 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10841826 |
| 60 | DNA replication_Homo sapiens_hsa03030 | 1.09141328 |
| 61 | Protein export_Homo sapiens_hsa03060 | 1.08680110 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07952351 |
| 63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.07000019 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.06301306 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05646775 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 1.05488672 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.04928272 |
| 68 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.02946146 |
| 69 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.01804287 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99405289 |
| 71 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.98017215 |
| 72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.97422676 |
| 73 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96281052 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 0.95892321 |
| 75 | Cell cycle_Homo sapiens_hsa04110 | 0.95482379 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94702476 |
| 77 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.94026367 |
| 78 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.93383864 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.91117400 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90079082 |
| 81 | RNA transport_Homo sapiens_hsa03013 | 0.88024719 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87179997 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87011938 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86454334 |
| 85 | Taste transduction_Homo sapiens_hsa04742 | 0.86439801 |
| 86 | Tight junction_Homo sapiens_hsa04530 | 0.84421377 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83384861 |
| 88 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.83146327 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82620426 |
| 90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81135758 |
| 91 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.80629053 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80577994 |
| 93 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.80504179 |
| 94 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80442222 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80415287 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.79191381 |
| 97 | Morphine addiction_Homo sapiens_hsa05032 | 0.79032783 |
| 98 | Axon guidance_Homo sapiens_hsa04360 | 0.78231578 |
| 99 | Nicotine addiction_Homo sapiens_hsa05033 | 0.78198764 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77064862 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76848637 |
| 102 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76711141 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72734982 |
| 104 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.69503819 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68850194 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68592983 |
| 107 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.68400029 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67442013 |
| 109 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66206389 |
| 110 | Long-term potentiation_Homo sapiens_hsa04720 | 0.65306194 |
| 111 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.65249512 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64779875 |
| 113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.64398341 |
| 114 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.63958652 |
| 115 | Peroxisome_Homo sapiens_hsa04146 | 0.63903039 |
| 116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63753951 |
| 117 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63433890 |
| 118 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63129679 |
| 119 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62972754 |
| 120 | Focal adhesion_Homo sapiens_hsa04510 | 0.62912259 |
| 121 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62741416 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61065149 |
| 123 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.60864074 |
| 124 | Base excision repair_Homo sapiens_hsa03410 | 0.60478693 |
| 125 | Long-term depression_Homo sapiens_hsa04730 | 0.59615160 |
| 126 | Adherens junction_Homo sapiens_hsa04520 | 0.57802362 |
| 127 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57453432 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57451072 |
| 129 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56479441 |
| 130 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.55924839 |
| 131 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.55328052 |
| 132 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54624097 |
| 133 | Spliceosome_Homo sapiens_hsa03040 | 0.54377755 |
| 134 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54257576 |
| 135 | Gap junction_Homo sapiens_hsa04540 | 0.53750148 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52883844 |
| 137 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52300073 |
| 138 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52113780 |
| 139 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51750797 |
| 140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51390725 |
| 141 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50844030 |
| 142 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.50202301 |
| 143 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50017860 |
| 144 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49010187 |
| 145 | Cocaine addiction_Homo sapiens_hsa05030 | 0.46817409 |
| 146 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46763267 |
| 147 | Glioma_Homo sapiens_hsa05214 | 0.46677363 |
| 148 | Olfactory transduction_Homo sapiens_hsa04740 | 0.46610560 |
| 149 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44750343 |
| 150 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43147480 |
| 151 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43065450 |
| 152 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42925330 |
| 153 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42847864 |
| 154 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39541030 |
| 155 | Salivary secretion_Homo sapiens_hsa04970 | 0.38616567 |
| 156 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38219057 |
| 157 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38089230 |
| 158 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38067307 |
| 159 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37550551 |
| 160 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37494709 |
| 161 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.35663569 |
| 162 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35627192 |
| 163 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35105289 |
| 164 | Melanogenesis_Homo sapiens_hsa04916 | 0.34473777 |
| 165 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34129476 |
| 166 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.32807822 |
| 167 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.32800179 |

